These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31616906)

  • 21. Epidemiologic approach of doping in sport. A review.
    Laure P
    J Sports Med Phys Fitness; 1997 Sep; 37(3):218-24. PubMed ID: 9407754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sport, Society, and Anti-Doping Policy: An Ethical Overview.
    Bloodworth AJ; McNamee M
    Med Sport Sci; 2017; 62():177-185. PubMed ID: 28571026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Education Interventions to Improve Knowledge, Beliefs, Intentions and Practices with Respect to Dietary Supplements and Doping Substances: A Narrative Review.
    Daher J; El Khoury D; Dwyer JJM
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition and outcome of a curriculum to prevent disordered eating and body-shaping drug use.
    Elliot DL; Moe EL; Goldberg L; DeFrancesco CA; Durham MB; Hix-Small H
    J Sch Health; 2006 Feb; 76(2):67-73. PubMed ID: 16466469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A strategy to reduce illicit drug use is effective in elite Australian football.
    Harcourt PR; Unglik H; Cook JL
    Br J Sports Med; 2012 Oct; 46(13):943-5. PubMed ID: 22893512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspective of pharmacists in Qatar regarding doping and anti-doping in sports.
    Mottram D; Khalifa S; Alemrayat B; Rahhal A; Ahmed A; Stuart M; Awaisu A
    J Sports Med Phys Fitness; 2016 Jun; 56(6):817-24. PubMed ID: 25784399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The unethicality of doping in sports.
    Palmi I; Berretta P; Tini A; Ricci G; Marinelli S
    Clin Ter; 2019; 170(2):e100-e101. PubMed ID: 30993304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge of pharmacy students about doping, and the need for doping education: a questionnaire survey.
    Shibata K; Ichikawa K; Kurata N
    BMC Res Notes; 2017 Aug; 10(1):396. PubMed ID: 28800770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Discussion of public health and decriminalization of doping].
    Pedraz MV
    Rev Saude Publica; 2013 Oct; 47(5):1011-4. PubMed ID: 24626508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential analysis of the doping behaviour templates in three types of sports.
    Rodek J; Idrizović K; Zenić N; Perasović B; Kondric M
    Coll Antropol; 2013 May; 37 Suppl 2():211-7. PubMed ID: 23914509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medicolegal aspects of doping in sports].
    Pruvost J; Depiesse F
    Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-doping Activities and Comprehensive Health Support for Young Athletes].
    Nakajima R
    Yakugaku Zasshi; 2022; 142(2):123-128. PubMed ID: 35110447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reporting doping in sport: national level athletes' perceptions of their role in doping prevention.
    Whitaker L; Backhouse SH; Long J
    Scand J Med Sci Sports; 2014 Dec; 24(6):e515-521. PubMed ID: 24673128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-doping reference for pharmacists].
    Kasashi K
    Yakugaku Zasshi; 2009 Dec; 129(12):1475-81. PubMed ID: 19952525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-doping policy development process in the sports world (1968~1999): focusing on IOC activities and passive response from Korea].
    Hwang ER; Kim TY
    Uisahak; 2014 Aug; 23(2):269-318. PubMed ID: 25223222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.
    Overbye M
    Int J Drug Policy; 2018 May; 55():14-30. PubMed ID: 29477956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Moral Foundation for Anti-Doping: How Far Have We Progressed? Where Are the Limits?
    Murray TH
    Med Sport Sci; 2017; 62():186-193. PubMed ID: 28571014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-doping control and public health: limits to the exposure of human health to risk in the name of sporting glory].
    Aith FM
    Rev Saude Publica; 2013 Oct; 47(5):1015-8. PubMed ID: 24626509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.